503 related articles for article (PubMed ID: 494363)
1. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
2. Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.
Drafta D; Prişcu A; Neacşu E; Gangură M; Schindler AE; Stroe E; Anghel C; Panaitescu G
J Steroid Biochem; 1983 Apr; 18(4):459-63. PubMed ID: 6834830
[TBL] [Abstract][Full Text] [Related]
3. Subcellular concentrations of estrone, estradiol, androstenedione and 17 beta-hydroxysteroid dehydrogenase (17-beta-OH-SDH) activity in malignant and non-malignant human breast tissues.
Mehta RR; Valcourt L; Graves J; Green R; Das Gupta TK
Int J Cancer; 1987 Sep; 40(3):305-8. PubMed ID: 3040598
[TBL] [Abstract][Full Text] [Related]
4. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
Saez S; Martin PM; Chouvet CD
Cancer Res; 1978 Oct; 38(10):3468-73. PubMed ID: 688231
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
[TBL] [Abstract][Full Text] [Related]
6. Clinical data and estradiol receptor evaluation in breast cancer biopsies.
Di Fronzo G; Bertuzzi A; Saccozzi R
Tumori; 1979 Apr; 65(2):221-8. PubMed ID: 462574
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
8. Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer.
Flågeng MH; Knappskog S; Gjerde J; Lønning PE; Mellgren G
PLoS One; 2015; 10(8):e0134351. PubMed ID: 26247365
[TBL] [Abstract][Full Text] [Related]
9. Estradiol 17 beta-hydroxysteroid dehydrogenase, a marker of breast cancer hormone dependency.
Fournier S; Brihmat F; Durand JC; Sterkers N; Martin PM; Kuttenn F; Mauvais-Jarvis P
Cancer Res; 1985 Jun; 45(6):2895-9. PubMed ID: 3857123
[TBL] [Abstract][Full Text] [Related]
10. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue.
van Landeghem AA; Poortman J; Nabuurs M; Thijssen JH
Cancer Res; 1985 Jun; 45(6):2900-6. PubMed ID: 3986816
[TBL] [Abstract][Full Text] [Related]
11. Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women.
Vermeulen A; Deslypere JP; Paridaens R; Leclercq G; Roy F; Heuson JC
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):515-25. PubMed ID: 3015631
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue estrogen production and metabolism in premenopausal women.
Hetemäki N; Mikkola TS; Tikkanen MJ; Wang F; Hämäläinen E; Turpeinen U; Haanpää M; Vihma V; Savolainen-Peltonen H
J Steroid Biochem Mol Biol; 2021 May; 209():105849. PubMed ID: 33610799
[TBL] [Abstract][Full Text] [Related]
13. Existence of receptors bound to endogenous estradiol in breast cancers of premenopausal and postmenopausal women.
Sakai F; Saez S
Steroids; 1976 Jan; 27(1):99-110. PubMed ID: 178073
[TBL] [Abstract][Full Text] [Related]
14. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
Hilborn E; Stål O; Jansson A
Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
[TBL] [Abstract][Full Text] [Related]
16. Concentration of cytosolic estrogen receptors in patients with postmenopausal osteoporosis.
Davidson BJ; Riggs BL; Coulam CB; Toft DO
Am J Obstet Gynecol; 1980 Feb; 136(4):430-3. PubMed ID: 7355923
[TBL] [Abstract][Full Text] [Related]
17. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
18. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
19. The prediction of hormonal dependency of mammary cancer.
Block GE; Jensen EV; Polley TZ
Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens.
Santner SJ; Santen RJ
J Steroid Biochem Mol Biol; 1993 May; 45(5):383-90. PubMed ID: 8388710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
